C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2009
12/15/2009	US7632824 Nucleobase sequence of a modified oligonucleotide complementary to a nucleic acid molecule encoding human Mcl-1, an antipoptoic protein of the Bcl-2 family; targeting and modulating expression of Mcl-1 in cells, tissue; antisense therapy, antitumor, -carcinogenic and -proliferative agents; autoimmune
12/15/2009	US7632823 Compositions of tRNA and uses thereof
12/15/2009	US7632822 For prophylaxis and therapy of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, skin disorders, allergy, asthma or a disease caused by a pathogen
12/15/2009	US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
12/15/2009	US7632801 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
12/15/2009	US7632677 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein
12/15/2009	US7632676 Plant virus vector
12/15/2009	US7632669 Lipolytic enzyme variants
12/15/2009	US7632667 Mutan endonuclease with substrate-specific cleavage activity
12/15/2009	US7632663 Method for microbially producing L-valine
12/15/2009	US7632661 Expression elements
12/15/2009	US7632660 protein is encoded by nucleic acid molecules that interact or bind to B-aggressive lymphoma (BAL) molecules, which are differentially expressed in non-Hodgkin's lymphoma; diagnostic use; biodrug for treating B-cell lymphoma
12/15/2009	US7632659 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
12/15/2009	US7632658 Method of using aminopeptidase to produce cleaved polypeptides
12/15/2009	US7632646 Tuberculosis diagnostic test
12/15/2009	US7632643 PCA3, PCA3 genes, and methods of use
12/15/2009	US7632618 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
12/15/2009	US7632516 Moraxella catarrhalis BASB115 polypeptides
12/15/2009	US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc
12/15/2009	US7632513 amino acid sequence of subunit A of a cholera toxin (CT-A) or a fragment of the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment, where in Ser-63 and Arg-192 are replaced with another amino acid
12/15/2009	US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
12/15/2009	US7632511 Yeast-based therapeutic for chronic hepatitis C infection
12/15/2009	US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
12/15/2009	US7632509 Methods to express recombinant proteins from lentiviral vectors
12/15/2009	US7632507 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders
12/15/2009	US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/15/2009	US7632503 Using human insulin-like growth factor-1 (IGF-1) fusion protein as therapeutic in treatment and prevention of muscular disorders
12/15/2009	US7632502 Immunoglobulin for diagnosis and prevention of yeast infections
12/15/2009	US7632492 Use of host cells in forming modified target molecules, including therapeutic molecules having non-natural amino acids in their sequence; biosynthesis; drug conjugates
12/15/2009	US7631752 Card-shaped storage case for articles of daily use and/or consumer articles
12/15/2009	CA2601208C Method of preventing or treating type 1 diabetes by gene therapy with a secreted form of glutamic acid decarboxylase.
12/15/2009	CA2511404C Canine cyp1a2 gene polymorphism
12/15/2009	CA2456037C Paget disease of bone
12/15/2009	CA2439872C Leporipox-based vector vaccines
12/15/2009	CA2421907C A screening method for a substance having hypoglycemic activity by using stat-induced inhibitor of stat function-1
12/15/2009	CA2411968C Protein glycosylation modification in pichia pastoris
12/15/2009	CA2385347C Method for regulating transcription of foreign genes
12/15/2009	CA2358787C Oil maintenance indicator
12/15/2009	CA2347905C P53 antisense agent and method
12/15/2009	CA2339235C Surfaces with reduced electroosmotic flow
12/15/2009	CA2337965C Attenuated equine herpesvirus
12/15/2009	CA2330545C Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/15/2009	CA2315885C .alpha.1, 4-galactosyltransferase and dna encoding thereof
12/15/2009	CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
12/15/2009	CA2294996C Angiotensin derivatives
12/15/2009	CA2291803C Methods for coexpression of more than one gene using at least one internal ribosome entry site (ires)
12/15/2009	CA2243088C Humanized green fluorescent protein genes and methods
12/15/2009	CA2240570C Mutant chimeric dna polymerase
12/15/2009	CA2226833C Adenovirus vectors for gene therapy
12/15/2009	CA2132985C Nucleotide sequences which hybridize specifically with a campylobacter jejuni genomic nucleic sequence
12/13/2009	CA2643886A1 Selection of personalized cancer therapy regimens using interfering rna functional screening
12/10/2009	WO2009149470A1 Vcp-based vectors for algal cell transformation
12/10/2009	WO2009149465A1 Transformation of algal cells
12/10/2009	WO2009149419A2 Variant alpha-amylases from bacillus subtilis and methods of use, thereof
12/10/2009	WO2009149395A2 Variant alpha-amylases from bacillus subtilis and methods of use, thereof
12/10/2009	WO2009149307A2 Compositions and methods for restoring mitochondrial electron transfer function
12/10/2009	WO2009149304A2 Plant gene regulatory elements
12/10/2009	WO2009149240A1 Deletion mutants for the production of isobutanol
12/10/2009	WO2009149233A1 Methods for the production of ips cells using non-viral approach
12/10/2009	WO2009149218A2 Novel proteins and methods of designing and using same
12/10/2009	WO2009149214A2 Compositions and methods for enhancing cellular transport of biomolecules
12/10/2009	WO2009149189A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009	WO2009149185A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009	WO2009149182A1 Modulation of gene expression through endogenous small rna targeting of gene promoters
12/10/2009	WO2009149094A2 Cytotoxic t cell defined egfr peptide and an optimized derivative peptide
12/10/2009	WO2009149091A1 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents
12/10/2009	WO2009149083A2 Non-hemolytic clya for excretion of proteins
12/10/2009	WO2009148613A1 Treatment of pain with gap junction modulation compounds
12/10/2009	WO2009148605A2 Methods for treating hypercholesterolemia
12/10/2009	WO2009148560A2 Methods and compositions for nucleic acid sequencing
12/10/2009	WO2009148336A1 Novel genes involved in biosynthesis
12/10/2009	WO2009148330A1 Compositions and methods for improving plants
12/10/2009	WO2009148194A1 Polynucleotide for releasing recombinant protein to the outside of eukaryotic cell
12/10/2009	WO2009148184A1 Method for detection of idiopathic interstitial pneumonia
12/10/2009	WO2009148177A1 Method for evaluation of developmental toxicity
12/10/2009	WO2009148150A1 Device for detection of influenza virus
12/10/2009	WO2009148149A1 Method for amplification of dna in cell
12/10/2009	WO2009148057A1 Reprogramming of blood cells
12/10/2009	WO2009147984A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene
12/10/2009	WO2009147918A1 Polyhydroxyalkanoate copolymer and manufacturing method therefor
12/10/2009	WO2009147864A1 Method for analysis/identification of antibody gene at one-cell level
12/10/2009	WO2009147742A1 Sirna of human osteopontin
12/10/2009	WO2009147673A1 Bacteria expressing a sequestration and secretion pathway from paracoccus marcusii and uses thereof
12/10/2009	WO2009147656A1 Compositions and methods for prognosis of gastric cancer
12/10/2009	WO2009147549A1 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging
12/10/2009	WO2009147519A1 Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
12/10/2009	WO2009147409A2 Aquatic plant
12/10/2009	WO2009147382A2 Expression vector
12/10/2009	WO2009147271A2 System for packaging high-capacity adenoviruses
12/10/2009	WO2009147246A1 Compounds reducing or inhibiting the expression of pkd1 for diagnosis and therapy of brain tumors
12/10/2009	WO2009147234A2 Anxiolytic composition containing alphas1-casein-derived peptides
12/10/2009	WO2009147210A1 Variants of a family 44 xyloglucanase
12/10/2009	WO2009147179A2 Process of producing male sterile monocotyledonous plants
12/10/2009	WO2009147127A1 Fatty acid dehydratases and uses thereof
12/10/2009	WO2009147015A1 Secretion-optimized microorganism
12/10/2009	WO2009146892A1 Process for generating a variant library of dna sequences
12/10/2009	WO2009146776A2 Method for isolating nucleic acids
12/10/2009	WO2009146775A2 Method for isolating short-chain nucleic acids
12/10/2009	WO2009146668A2 Regulatory gene element comprising promotor/enhancer protected from dna methylation and gene expression silencing
12/10/2009	WO2009146556A1 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof

1 ... 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 ... 4023